These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23790649)

  • 21. Type I gore-tex laryngoplasty for glottic incompetence in mobile vocal folds.
    Buckmire RA; Bryson PC; Patel MR
    J Voice; 2011 May; 25(3):288-92. PubMed ID: 20236795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acoustic evaluation of Isshiki type III thyroplasty for treatment of mutational voice disorders.
    Li GD; Mu L; Yang S
    J Laryngol Otol; 1999 Jan; 113(1):31-4. PubMed ID: 10341916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stiffness of the vocal cord in dysphonia-its assessment and treatment.
    Isshiki N; Ohkawa M; Goto M
    Acta Otolaryngol Suppl; 1984; 419():167-74. PubMed ID: 6599227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relaxation thyroplasty for mutational falsetto treatment.
    Remacle M; Matar N; Verduyckt I; Lawson G
    Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):105-9. PubMed ID: 20336921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of thyroplasty in the management of sulcus vocalis.
    Kandoğan T
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):13-7. PubMed ID: 17483605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feminization laryngoplasty: assessment of surgical pitch elevation.
    Thomas JP; Macmillan C
    Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2695-700. PubMed ID: 23632870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of type II thyroplasty for adductor spasmodic dysphonia.
    Chan SW; Baxter M; Oates J; Yorston A
    Laryngoscope; 2004 Sep; 114(9):1604-8. PubMed ID: 15475790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wendler glottoplasty: an effective pitch raising surgery in male-to-female transsexuals.
    Mastronikolis NS; Remacle M; Biagini M; Kiagiadaki D; Lawson G
    J Voice; 2013 Jul; 27(4):516-22. PubMed ID: 23809571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relaxation laryngoplasty in the management of mutational falsetto].
    Wang LP; Zhou Y; Zhang YF; Li GD
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Sep; 44(9):749-52. PubMed ID: 20079099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel approach of medialization thyroplasty with arytenoid adduction performed under general anesthesia with a laryngeal mask.
    Stow NW; Lee JW; Cole IE
    Otolaryngol Head Neck Surg; 2012 Feb; 146(2):266-71. PubMed ID: 22075075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and voice analysis of patients with mutational dysphonia: clinical significance of diplophonia and closed quotients.
    Lim JY; Lim SE; Choi SH; Kim JH; Kim KM; Choi HS
    J Voice; 2007 Jan; 21(1):12-9. PubMed ID: 16426813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II thyroplasty changes cortical activation in patients with spasmodic dysphonia.
    Tateya I; Omori K; Kojima H; Naito Y; Hirano S; Yamashita M; Ito J
    Auris Nasus Larynx; 2015 Apr; 42(2):139-44. PubMed ID: 25199736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phonosurgery in gender dysphoria.
    Moerman M; Vermeersch H; Van Borsel J; Wallaert P
    Acta Chir Belg; 2000; 100(2):58-61. PubMed ID: 10925714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 thyroplasty for spasmodic dysphonia: fixation using a titanium bridge.
    Isshiki N; Yamamoto I; Fukagai S
    Acta Otolaryngol; 2004 Apr; 124(3):309-12. PubMed ID: 15141760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Montgomery thyroplasty implant under local anesthesia for unilateral laryngeal paralysis].
    Michel F; Hans S; Crevier-Buchman L; Brasnu D; Menard M; Laccourreye O
    Ann Otolaryngol Chir Cervicofac; 2003 Nov; 120(5):259-67. PubMed ID: 14726844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The applicability of the dysphonia severity index and the voice handicap index in evaluating effects of voice therapy and phonosurgery.
    Hakkesteegt MM; Brocaar MP; Wieringa MH
    J Voice; 2010 Mar; 24(2):199-205. PubMed ID: 19185461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term voice outcomes after thyroplasty for unilateral vocal fold paralysis.
    Ryu IS; Nam SY; Han MW; Choi SH; Kim SY; Roh JL
    Arch Otolaryngol Head Neck Surg; 2012 Apr; 138(4):347-51. PubMed ID: 22431862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioplastique injection laryngoplasty: voice performance outcome.
    Hamilton DW; Sachidananda R; Carding PN; Wilson JA
    J Laryngol Otol; 2007 May; 121(5):472-5. PubMed ID: 17164022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroplasty type I with Montgomery implant among native French language speakers with unilateral laryngeal nerve paralysis.
    Laccourreye O; El Sharkawy L; Holsinger FC; Hans S; Ménard M; Brasnu D
    Laryngoscope; 2005 Aug; 115(8):1411-7. PubMed ID: 16094114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term quantitative results of an Isshiki type 4 thyroplasty-a case study.
    Gibbins N; Bray D; Harries ML
    J Voice; 2011 May; 25(3):283-7. PubMed ID: 20335003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.